pf-3512676 and Lymphoma--T-Cell

pf-3512676 has been researched along with Lymphoma--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for pf-3512676 and Lymphoma--T-Cell

Article	Year
Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion. Leukemia & lymphoma, 2012, Volume: 53, Issue:1 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemokine CCL5; Cytokines; Dose-Response Relationship, Drug; Humans; Imiquimod; Interleukin-10; Lymphoma, T-Cell; Mice; Oligodeoxyribonucleotides; Time Factors; Toll-Like Receptors	2012

Article

Year

Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion.

Leukemia & lymphoma, 2012, Volume: 53, Issue:1

Topics: Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemokine CCL5; Cytokines; Dose-Response Relationship, Drug; Humans; Imiquimod; Interleukin-10; Lymphoma, T-Cell; Mice; Oligodeoxyribonucleotides; Time Factors; Toll-Like Receptors

2012